Brighton Jones LLC’s 10x Genomics TXG Stock Holding History

Brighton Jones LLC’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$479K	Buy	+22,549	New	+$451K	0.01%	716
2025 Q4	–	Sell	-22,349	Closed	-$261K	–	882
2025 Q3	$261K	Sell	22,349 -338	-1%	-$4.41K	0.01%	863
2025 Q2	$263K	Buy	+22,687	New	+$207K	0.01%	778
2024 Q2	–	Sell	-5,395	Closed	-$202K	–	666
2024 Q1	$202K	Buy	+5,395	New	+$237K	0.01%	578
2022 Q1	–	Sell	-1,459	Closed	-$217K	–	551
2021 Q4	$217K	Buy	1,459 +13	+0.9%	+$1.99K	0.01%	474
2021 Q3	$211K	Hold	1,446	–	–	0.01%	445
2021 Q2	$283K	Buy	1,446 +5	+0.3%	+$905	0.01%	361
2021 Q1	$261K	Buy	+1,441	New	+$249K	0.02%	340

Other funds holding TXG

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

QCM

Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brighton Jones LLC's TXG Position: Q1 2026 in Review

Brighton Jones LLC opened a new position in 10x Genomics (TXG) in Q1 2026: 22,549 shares worth $479K. The stake represents 0.01% of the portfolio and ranks #716 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in TXG as recently as Q3 2025.

Brighton Jones LLC first reported a position in TXG in Q1 2021 and has held it in 8 quarters since. 330 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

Brighton Jones LLC held 22,549 shares of 10x Genomics worth $479K as of Q1 2026.
10x Genomics was a new Brighton Jones LLC position in Q1 2026.
10x Genomics made up 0.01% of Brighton Jones LLC's portfolio in Q1 2026, its #716 holding.
Brighton Jones LLC first reported a position in 10x Genomics in Q1 2021 and has held it in 8 quarters since.
330 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.